Aspirin-induced bilateral renal hemorrhage after extracorporeal shock wave lithotripsy therapy: implications and conclusions.
The Journal of urology · 1990 · Vol. 143 · Issue 4 · 791-2
Academy Summary
Ruiz and Saltzman reported a severe case of bilateral renal haemorrhage following extracorporeal shock wave lithotripsy in a patient who had taken aspirin during the week before treatment.
Following SWL, the patient developed chest pain requiring intensive-care monitoring and cardiac evaluation. During the subsequent two days, the haematocrit fell dramatically from 48% to 23%, and multiple blood transfusions were required. Imaging demonstrated bilateral intrarenal, subcapsular, and perirenal haematomas.
Only after treatment was it recognised that the patient had been taking aspirin daily within one week of SWL. The authors proposed that aspirin-related platelet inhibition may have predisposed the patient to unusually severe renal bleeding following shock-wave exposure.
Although this is only a single case report, it is historically important because it illustrates the potential interaction between SWL-induced renal microvascular injury and impaired platelet function.
The paper should not be interpreted as proving that aspirin inevitably causes haemorrhage during SWL. Rather, it provides an early clinical warning that antiplatelet medication must be actively identified and incorporated into pre-treatment bleeding-risk assessment.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
